Adalimumab Interactions
There are 550 drugs known to interact with adalimumab, along with 8 disease interactions. Of the total drug interactions, 300 are major, 241 are moderate, and 9 are minor.
- View all 550 medications that may interact with adalimumab
- View adalimumab disease interactions (8)
Most frequently checked interactions
View interaction reports for adalimumab and the medicines listed below.
- Activated Charcoal (charcoal)
- Adderall (amphetamine / dextroamphetamine)
- Advair Diskus (fluticasone / salmeterol)
- Celebrex (celecoxib)
- Cymbalta (duloxetine)
- Eliquis (apixaban)
- Enbrel (etanercept)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flexeril (cyclobenzaprine)
- Imuran (azathioprine)
- Iodides (sodium iodide)
- Iron Sulfate (ferrous sulfate)
- Jardiance (empagliflozin)
- Lyrica (pregabalin)
- Methotrexate LPF Sodium (methotrexate)
- Metoprolol Succinate ER (metoprolol)
- Norco (acetaminophen / hydrocodone)
- Ozempic (semaglutide)
- Paracetamol (acetaminophen)
- Paxlovid (nirmatrelvir / ritonavir)
- Plaquenil (hydroxychloroquine)
- Protonix (pantoprazole)
- Spiriva (tiotropium)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D2 (ergocalciferol)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Zofran (ondansetron)
- Zyrtec (cetirizine)
Adalimumab disease interactions
There are 8 disease interactions with adalimumab which include:
- infections
- malignancies
- neurologic reactions
- tuberculosis
- CHF
- COPD
- hematologic abnormalities
- hepatitis B
More about adalimumab
- adalimumab consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (737)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: antirheumatics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.